We found that the roles of CD96 and IDO1 are closely related, suggesting that tumor-immune regulation by IDO1 could be of prognostic relevance in cervical cancer.[26] These results suggested that IDO1 may influence the therapeutic response in cervical cancer via immune checkpoint regulation. Here, CD96 is linked to cervical carcinoma.